Mereo Biopharma AGM resolutions pass

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Mereo BioPharma, a clinical stage biopharmaceutical company focused on rare diseases, announced all resolutions proposed at the Annual General Meeting, held yesterday, were duly passed.

At 9:25am: (LON:MPH) Mereo Biopharma Group Ltd share price was -3.5p at 57.5p